Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial

The aim of this study was to evaluate the efficacy and safety of recombinant human adenovirus-p53 (rhAd-p53) combined with neoadjuvant chemotherapy in treatment of locally advanced cervical cancer (LACC). A total of 40 patients with LACC (stage IB2 to IIIA) were randomized into 2 groups (n=20 each):...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Jie, Zhou, Jian, Fu, Min, Liang, Li, Deng, Qiaoling, Liu, Xiaoyun, Liu, Fumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431581/
https://www.ncbi.nlm.nih.gov/pubmed/28529585
http://dx.doi.org/10.3892/ol.2017.5901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431581/
https://www.ncbi.nlm.nih.gov/pubmed/28529585
http://dx.doi.org/10.3892/ol.2017.5901

Ejemplares similares